Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

39.24 USD +0.32 (+0.82%)
Official Closing Price Updated: 6:48 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,823,883
Open 39.03
Bid (Size) 39.25 (17)
Ask (Size) 39.29 (5)
Prev. Close 38.92
Today's Range 38.96 - 39.31
52wk Range 31.43 - 47.35
Shares Outstanding 2,479,760,852
Dividend Yield 5.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness... 
From PR Newswire
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert

Performance

YTD
+3.97%
+3.97%
1 Month
+8.13%
+8.13%
3 Month
+11.41%
+11.41%
6 Month
-4.01%
-4.01%
1 Year
-15.58%
-15.58%

More News

Read More
Novartis and GSK Announce Collaboration to Support Scientific Research Into Genetic Diversity in Africa
Tags Responsible Business & Employee Engagement Innovation & Technology africa
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
From GlobeNewswire News Releases
Eligo inks deal with GSK potentially worth up to $224M
From PR Newswire
Pfizer, GSK-Backed ViiV First To Get FDA Approval For HIV Shots: What You Need To Know
Tags Benzinga PFE HIV treatment
From Benzinga
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
From Business Wire News Releases
3 Blockbuster Drug Launches to Watch This Year
Tags GSK JNJ LLY
From Motley Fool
Why Vir Biotechnology Stock Vaulted Higher Today
Tags GSK Market News VIR
From Motley Fool
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
Tags LLY Health Care FDA
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
Tags IDRA INSM PROF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.